Angina Pectoris: Symptoms, Diagnosis, Causes, Medications and Treatments

What is Angina Pectoris?

Angina pectoris is a medical term used to describe a distinctive type of discomfort, often true chest pain, that occurs when a part of the heart muscle is not receiving an adequate supply of oxygenated blood. The word “angina” comes from the Latin meaning “strangling” or “tightening”, and indeed many patients describe it precisely as a strangling, pressing, or squeezing sensation in the chest.

While chest pain is the most recognizable hallmark, angina pectoris can also manifest through a wide range of associated symptoms, including:

• Shortness of breath
• Sweating
• Dizziness
• Fatigue
• Fainting (syncope)

Some patients do not experience what they would call “pain” at all. Instead, they report a sensation of pressure, tingling, heaviness, or burning in the chest, which may radiate to the shoulders, arms, neck, jaw, throat, or back. A significant number of patients describe the sensation as being remarkably similar to indigestion or heartburn, which can unfortunately lead to dangerous delays in seeking medical attention.

Understanding why angina happens requires a brief look at cardiac physiology. The heart is a uniquely specialized muscle. In fact, it is the only muscle in the human body that must work continuously, without rest, for an entire lifetime. Like all muscles, the heart requires a constant, uninterrupted supply of oxygen and nutrients to function. This supply is delivered through the coronary arteries, a network of blood vessels that wrap around the surface of the heart. When these arteries become narrowed or blocked, even partially, the heart muscle may not receive sufficient blood, particularly when demand increases, for example during physical exertion or emotional stress. This mismatch between oxygen supply and oxygen demand is the fundamental mechanism underlying angina pectoris.

It is critically important to understand that angina is not a disease in itself. It is a symptom: a warning sign of an underlying cardiac problem that, in the vast majority of cases, is coronary artery disease (CAD). The most typical underlying pathology involves the formation of atherosclerotic plaques on the inner walls of the coronary arteries, which progressively narrow the lumen of these vessels and restrict blood flow to the heart muscle.

While angina does not usually represent an immediate life-threatening emergency in and of itself, it is a critical clinical signal that must never be ignored. Its presence indicates a significantly elevated risk of future heart attack (myocardial infarction) or stroke and demands prompt medical evaluation and ongoing management. Recognizing and responding appropriately to angina can genuinely be life-saving.

---

Causes

The causes of angina pectoris are, in most cases, directly tied to the causes of coronary artery disease (CAD). The underlying mechanism that unites them is a problem with blood supply to the myocardium, the heart muscle.

Scientific research has established that coronary artery disease develops when the inner layers (endothelium) of the coronary arteries become damaged. Over time, this damage triggers a complex inflammatory response that promotes the deposition of fatty substances, cholesterol, calcium, and cellular debris on the arterial walls, a process known as atherosclerosis. The result is the formation of plaques that progressively narrow the coronary arteries and impair blood flow.

The main factors responsible for initiating this damaging process include:

• Smoking: Tobacco smoke contains thousands of chemicals that directly injure the vascular endothelium and promote inflammation, platelet aggregation, and oxidative stress.
• High blood cholesterol and lipid levels: Elevated LDL (“bad”) cholesterol is a primary driver of atherosclerotic plaque formation.
• High blood pressure (hypertension): Persistent high pressure damages arterial walls and accelerates atherosclerosis.
• Elevated blood sugar levels: Whether due to insulin resistance or frank diabetes mellitus, high blood glucose promotes vascular inflammation and damage.

These factors, individually and in combination, are the primary drivers of atherosclerosis, not only in the coronary arteries but throughout the entire arterial system of the body.

It is important to understand that not all atherosclerotic plaques behave in the same way:

• Hard, stable plaques: These produce a chronic, progressive narrowing and stiffening of the coronary arteries, reducing blood flow in a predictable, gradual manner. They tend to produce the stable, effort-related pattern of angina that patients can learn to predict and manage.
• Soft, vulnerable plaques: These are more prone to rupture. When a vulnerable plaque tears open, it triggers the rapid formation of a blood clot (thrombus) that can partially or completely block the artery. This is a potentially catastrophic event that can cause unstable angina or, in the worst cases, a full myocardial infarction. The behavior of these plaques is by definition unpredictable.

Both mechanisms can produce angina, but they represent very different clinical scenarios with different levels of urgency and different treatment approaches.

Types of Angina

Medical science recognizes four distinct types of angina pectoris, each with its own mechanism, clinical presentation, triggers, and management approach.

1. Stable Angina

Stable angina is by far the most common form. It occurs when the heart is forced to work harder than usual, for example during physical exertion, emotional stress, or exposure to cold, and the narrowed coronary arteries cannot increase blood flow sufficiently to meet the increased demand. The key feature of stable angina is its predictability: episodes tend to occur under similar circumstances, last a relatively short time (typically less than five minutes), and respond reliably to rest and to short-acting nitrate medications.

Stable angina is not a heart attack, but it is a powerful warning signal. Its presence indicates that the coronary arteries are significantly narrowed and that the risk of future adverse cardiac events is meaningfully elevated.

2. Unstable Angina

Unstable angina is a more serious and medically urgent condition. Unlike stable angina, it does not follow a predictable pattern. Episodes may occur at rest, without any obvious trigger, and the pain tends to be more severe, last longer, and respond poorly or not at all to rest and standard medications. Unstable angina is most commonly caused by the rupture of an atherosclerotic plaque and the formation of a blood clot that partially obstructs a coronary artery.

Because unstable angina can be a precursor to a full myocardial infarction, it is considered a medical emergency and requires immediate evaluation and treatment. It is classified together with certain types of myocardial infarction under the umbrella term “Acute Coronary Syndrome”.

3. Variant Angina (Prinzmetal’s Angina)

Variant angina, also known as Prinzmetal’s angina or vasospastic angina, is a rarer form caused not by fixed plaque-related narrowing but by sudden, intense spasms in one or more coronary arteries. These spasms temporarily cause the artery walls to contract sharply, dramatically reducing or completely halting blood flow to the affected area of the heart muscle. Variant angina typically occurs at rest, most often between midnight and early morning, and can produce severe chest pain. Paradoxically, however, it generally responds very well to specific medications (particularly calcium channel blockers and nitrates).

4. Microvascular Angina

Microvascular angina (formerly called Syndrome X) is caused by dysfunction in the smallest coronary blood vessels, the microcirculation, rather than the large epicardial arteries. Because these tiny vessels are too small to be seen on standard coronary angiography, microvascular angina was historically underdiagnosed and its mechanism misunderstood. The pain episodes in microvascular angina can be particularly prolonged and severe, and they can occur both during exertion and at rest. This form of angina responds reasonably well to medications and is particularly important to recognize because it is significantly more common in women, especially around the time of menopause.

Triggering Factors

The specific triggers for angina episodes vary depending on the type.

Triggers for Stable Angina

The most common and important trigger for stable angina is physical activity. When the coronary arteries are significantly narrowed, they may still be able to supply enough blood to meet the heart’s relatively modest oxygen demands at rest. However, when physical activity (walking, climbing stairs, running, sexual activity) or emotional arousal causes the heart to beat faster and work harder, the demand for oxygen increases rapidly, and the narrowed arteries simply cannot keep pace. The result is ischemia (insufficient blood supply) and the characteristic angina pain.

Other important triggers for stable angina include:

• Emotional stress: Anxiety, anger, and acute psychological distress cause the release of adrenaline and other stress hormones that increase heart rate and blood pressure, raising myocardial oxygen demand.
• Extreme temperatures: Both intense heat and cold can trigger angina. Cold exposure in particular causes peripheral vasoconstriction, raising blood pressure and increasing cardiac workload.
• Heavy meals: Eating a large meal diverts blood flow to the gastrointestinal tract and can also indirectly increase cardiac demand, particularly in susceptible individuals.
• Smoking: Each cigarette causes an acute increase in heart rate, blood pressure, and carboxyhemoglobin levels, reducing the oxygen-carrying capacity of the blood and precipitating ischemia.

Triggers for Unstable Angina

Unstable angina is primarily triggered by the rupture of an atherosclerotic plaque within a coronary artery, followed by the formation of a blood clot. This process can occur without any external trigger, such as at rest, during sleep, or with minimal physical activity. The clot may partially dissolve and reform, leading to recurrent episodes of ischemia that are by definition unpredictable and potentially life-threatening.

Triggers for Variant Angina

Variant angina is caused by a sudden coronary artery spasm. The exact mechanisms that initiate these spasms are not always fully understood, but recognized triggers include:

• Exposure to cold
• Emotional stress
• Certain vasoconstricting medications
• Smoking
• Use of stimulant drugs, particularly cocaine

Triggers for Microvascular Angina

Microvascular angina can be triggered by both physical and emotional stressors, and it often first manifests during routine daily activities or moments of mental stress. Over time, episodes may become more frequent and intrusive.

Risk Factors

Because angina is fundamentally a symptom of underlying coronary artery disease (or coronary microvascular disease), its risk factors mirror those of these conditions precisely:

• High cholesterol (hyperlipidemia)
• High blood pressure (hypertension)
• Smoking (active or passive)
• Insulin resistance or diabetes mellitus
• Overweight or obesity
• Metabolic syndrome
• Physical inactivity: A sedentary lifestyle is independently associated with a significantly higher risk of cardiovascular disease.
• Unhealthy diet: Diets high in saturated fats, trans fats, refined sugars, and sodium promote atherosclerosis and hypertension.
• Age: The risk increases progressively with age: for men after 45 and for women after 55. However, younger individuals with multiple risk factors are by no means immune.
• Family history of premature heart disease: A family history of coronary artery disease in a first-degree relative (parent, sibling) before the age of 55 (men) or 65 (women) significantly elevates personal risk.

It is worth noting some important variations in how angina affects different population groups:

• Angina affects men and women equally in overall prevalence, but its presentation and the underlying mechanism can differ. Women are more likely to have microvascular angina, which accounts for approximately 70% of all microvascular angina cases occurring in women around the time of menopause.
• Unstable angina occurs more frequently in older adults, reflecting the accumulation of atherosclerotic burden with age.
• Variant (Prinzmetal’s) angina is relatively rare, accounting for approximately 2 out of every 100 angina cases, and tends to affect younger patients than other forms, often without the classic cardiovascular risk factor profile.

---

Symptoms

The cardinal symptoms of angina pectoris are pain and discomfort, but these terms can encompass a surprisingly wide range of sensations that patients describe in highly varied ways. Understanding this variability is essential for timely recognition and diagnosis.

The discomfort is most commonly described as:

• A pressure or squeezing sensation, as if a heavy weight is sitting on the chest
• A burning or tightening feeling in the chest or breastbone area
• A sensation of fullness or constriction behind the sternum

Most commonly, the pain or discomfort begins behind the breastbone (sternum), but it frequently radiates to other areas:

• Arms and shoulders (classically the left arm, but both arms can be affected)
• Neck and jaw
• Throat
• Back (particularly between the shoulder blades)

In some patients, the discomfort is so similar to heartburn or indigestion that it is initially, and dangerously, attributed to a gastrointestinal cause.

Additional signs and symptoms that may accompany the chest discomfort include:

• Nausea and vomiting
• Extreme fatigue or weakness
• Shortness of breath (dyspnea)
• Sweating (often described as cold or clammy)
• Dizziness or lightheadedness
• Muscle weakness

There are also important variations in symptom presentation across different patient populations:

• Women are more likely to experience atypical symptoms, such as discomfort in the neck, jaw, throat, abdomen, or back, rather than the classic crushing chest pain. This can contribute to diagnostic delays and undertreatment in female patients, a well-documented problem in cardiovascular medicine.
• Elderly individuals may present with shortness of breath as a primary or even sole symptom. Weakness, dizziness, and confusion can also mask or replace the typical chest discomfort, further complicating recognition.
• People with diabetes are particularly prone to atypical presentations, including shortness of breath and fatigue without prominent chest pain, because diabetes-related neuropathy can blunt the perception of pain (so-called “silent ischemia”).

Stable Angina: Characteristic Symptoms

In stable angina, the pain or discomfort:

• Occurs predictably in association with increased cardiac workload, most commonly during physical exertion (for example, walking, climbing stairs, carrying heavy objects, or sexual activity), but also during emotional stress, exposure to cold, or after a heavy meal.
• It is not a surprise; the patient typically learns to recognize the circumstances that precipitate it.
• Lasts a limited time, typically five minutes or less.
• Is relieved by rest and/or by sublingual nitroglycerin within a few minutes.
• May resemble gas discomfort or indigestion.
• May radiate from the chest to the arms, shoulders, jaw, neck, or back.

Unstable Angina: Characteristic Symptoms

In unstable angina, the pain or discomfort:

• Occurs unpredictably, often at rest, during sleep, or with minimal or no exertion.
• Is new, unexpected, or represents a change from a previous stable pattern of angina.
• Is more severe and lasts longer than stable angina, potentially 20 to 30 minutes or more.
• Is not reliably relieved by rest or nitroglycerin.
• May progressively worsen over time.
• Signals a high risk of imminent heart attack: this is a medical emergency.

Any new onset of chest pain or a significant change in a previously stable angina pattern must be treated as potentially unstable angina until proven otherwise, and requires immediate medical evaluation.

Variant (Prinzmetal’s) Angina: Characteristic Symptoms

In variant angina, the pain or discomfort:

• Typically occurs at rest, most often at night or in the early morning hours (between midnight and 8 a.m.).
• Can be severe in intensity.
• May be accompanied by ECG changes (ST elevation) during the episode.
• Responds well to calcium channel blockers and nitrates.

Microvascular Angina: Characteristic Symptoms

In microvascular angina, the pain or discomfort:

• Tends to be more severe and of longer duration than other forms of angina.
• May be accompanied by shortness of breath, sleep disturbances, profound fatigue, and a general lack of energy.
• Is often first noticed during routine daily activities or periods of mental stress.
• Can be challenging to diagnose because standard coronary angiography may appear normal.

Differential Diagnosis

The differential diagnosis of chest pain is broad, and several other serious conditions can mimic angina pectoris. These must be considered and excluded through appropriate clinical assessment:

• Pulmonary embolism: A blockage in a pulmonary artery, which can cause sudden, sharp chest pain and severe shortness of breath.
• Pneumonia or lung infection: Can produce pleuritic chest pain (sharp pain worsened by breathing).
• Aortic dissection: A tear in the inner layer of the aorta, typically described as a sudden, tearing pain that radiates to the back. A true surgical emergency.
• Aortic stenosis: Narrowing of the aortic valve, which can restrict blood flow and cause exertional chest pain and syncope.
• Hypertrophic cardiomyopathy: A structural heart disorder that can cause angina-like pain, particularly during exertion.
• Pericarditis: Inflammation of the pericardium (the sac surrounding the heart), often producing sharp, positional chest pain.
• Panic attack: Acute anxiety attacks can cause chest tightness, shortness of breath, and palpitations that closely mimic cardiac symptoms.
• Gastroesophageal reflux disease (GERD) and esophageal spasm.
• Costochondritis: Inflammation of the cartilage connecting the ribs to the sternum.
• Musculoskeletal chest wall pain.

A careful clinical history, physical examination, and targeted diagnostic tests are essential to distinguish angina from these other conditions.

Angina or Heart Attack? Knowing the Critical Difference

This is perhaps the most important distinction in emergency cardiology. Both angina and heart attack (myocardial infarction) are caused by reduced blood flow to the heart, but they differ fundamentally in severity and consequence.

In angina, the blood supply is reduced but not completely interrupted, and the heart muscle is therefore ischemic (oxygen-deprived) but not permanently damaged. The discomfort resolves when blood flow is restored, either through rest, medication, or the resolution of a spasm.

In a heart attack, one or more coronary arteries become completely blocked, most often by a blood clot forming on a ruptured atherosclerotic plaque. Without blood flow, the affected heart muscle cells begin to die irreversibly within minutes. The longer the artery remains blocked, the greater the permanent damage, which is why a heart attack is a true medical emergency where “time is muscle”.

The three key clinical differences between angina and a heart attack are:

1. The pain is stronger and more severe during a heart attack.
2. The pain lasts longer, typically more than 20 to 30 minutes (as opposed to the 5 minutes or less typical of stable angina).
3. Rest and medications do not relieve the pain during a heart attack.

Additional warning signs that are more typical of a heart attack than of angina include profound sweating, extreme pallor, a feeling of “doom”, nausea, and vomiting.

If any doubt exists, treat the situation as a heart attack and call emergency services immediately. Never wait to see if the pain resolves on its own.

It is also critical to remember that untreated or undertreated angina, particularly unstable angina, can itself progress to a full heart attack.

---

Diagnosis

The modern diagnostic approach to angina pectoris goes far beyond simply confirming the presence of chest symptoms. The goal is to characterize the patient’s global cardiovascular risk profile, determine the underlying mechanism (ischemia due to obstructive disease vs. vasospasm vs. microvascular dysfunction), assess the anatomical state of the coronary arteries, and guide an individualized treatment strategy.

Clinical History and Physical Examination

The diagnostic process always begins with a thorough clinical history (anamnesis). The physician will ask detailed questions about:

• The character of the chest discomfort (pressure, burning, squeezing, stabbing)
• Its location and radiation pattern
• Duration of episodes
• Triggering and relieving factors (exertion, rest, nitrates)
• Associated symptoms (shortness of breath, sweating, nausea, palpitations)
• Personal and family history of cardiovascular disease
• Presence of known risk factors (hypertension, diabetes, smoking, hyperlipidemia)

A careful physical examination follows, evaluating blood pressure, heart rate and rhythm, heart sounds, peripheral pulses, and signs of heart failure.

Blood Tests and Biomarkers

Laboratory investigations are fundamental to both diagnosis and risk stratification:

• Lipid profile (cholesterol): Total cholesterol, LDL, HDL, and triglycerides to assess atherosclerotic risk.
• Blood glucose (glycemia) and glycated hemoglobin (HbA1c): To detect diabetes or pre-diabetes.
• High-sensitivity troponin: This is particularly important when unstable angina or acute myocardial infarction needs to be excluded. Troponin is released into the bloodstream when heart muscle cells are damaged, making it a highly sensitive marker of acute myocardial injury.
• C-reactive protein (CRP) and other inflammatory markers: Useful for overall cardiovascular risk assessment.
• Complete blood count, kidney function, thyroid function: To identify contributing factors or comorbidities.

Electrocardiogram (ECG)

The electrocardiogram (ECG) is a rapid, non-invasive recording of the heart’s electrical activity. When performed at rest, it may reveal:

• Rhythm disturbances (arrhythmias)
• Evidence of a previous (silent) myocardial infarction
• Signs of left ventricular hypertrophy
• Acute ST-segment changes suggesting ongoing ischemia

However, it is important to recognize that in many patients with stable angina, the resting ECG may be entirely normal outside of an episode. This does not exclude coronary artery disease.

A 12-lead ECG performed during a symptomatic episode (if possible) has much higher diagnostic value, as ischemic changes are far more likely to be present.

Stress Testing and Functional Imaging

Stress tests are designed to provoke and detect myocardial ischemia under controlled conditions by increasing the heart’s workload.

• Exercise stress test (treadmill or bicycle ergometry): The patient exercises on a treadmill or bicycle while the ECG is continuously monitored. The development of characteristic ECG changes, symptoms, or blood pressure abnormalities during exercise strongly suggests significant coronary artery disease. Sensitivity is moderate, which is why it is often combined with imaging.
• Stress echocardiography: Uses ultrasound imaging before and after pharmacological or exercise stress to detect areas of the heart wall that do not contract normally during increased demand, which is a sign of underlying ischemia.
• Nuclear stress test (myocardial perfusion imaging): Uses a small amount of radioactive tracer to produce images of blood flow through the heart muscle at rest and during stress, detecting areas of reduced perfusion.
• Cardiac magnetic resonance (CMR) stress imaging: An increasingly utilized, highly accurate method that can assess both cardiac function and myocardial perfusion without radiation exposure.

Anatomic Imaging: Coronary CT Angiography (CCTA)

Coronary CT angiography (CCTA) uses advanced computed tomography technology to produce highly detailed, three-dimensional images of the coronary arteries and the plaques within them, all completely non-invasively. Current European and American guidelines increasingly position CCTA as a first-line investigation for patients with suspected stable angina and low to intermediate pre-test probability of obstructive coronary artery disease. It can:

• Directly visualize the lumen of the coronary arteries and detect stenoses
• Characterize plaque composition (calcified vs. non-calcified)
• Identify high-risk plaque features
• Provide prognostic information beyond stenosis severity (coronary artery calcium scoring)

Invasive Coronary Angiography (Cardiac Catheterization)

Coronary angiography (cardiac catheterization) remains the gold standard for definitively diagnosing coronary artery disease and guiding revascularization decisions. During this procedure:

• A thin, flexible catheter is inserted (typically via the wrist or groin) and guided to the opening of the coronary arteries.
• A contrast dye is injected and X-ray images are taken, revealing any narrowing or blockages in real time.
• Additional measurements, such as fractional flow reserve (FFR), can be performed to assess the functional significance of intermediate stenoses.

Coronary angiography is typically reserved for patients with high-risk features on non-invasive testing, those whose symptoms cannot be controlled with optimal medical therapy, or those being considered for revascularization (angioplasty or bypass surgery).

---

Treatment and Management

The treatment of angina pectoris has two overarching goals: improving quality of life by alleviating symptoms and enabling normal daily activities, and improving prognosis by reducing the risk of major adverse cardiovascular events such as myocardial infarction and cardiovascular death.

Modern management is always individualized and multifaceted, integrating lifestyle modification, pharmacological therapy, and mechanical revascularization when indicated. No single approach is sufficient in isolation.

Pharmacological Approach

Drug therapy for angina pectoris is organized around two complementary strategies: symptomatic relief during acute episodes and long-term secondary prevention of adverse events.

Medications for Acute Symptom Relief

Short-acting nitrates (nitroglycerin): Sublingual nitroglycerin, available as a tablet or spray, remains the cornerstone of acute angina management. It acts within 1 to 3 minutes by dilating coronary arteries and peripheral blood vessels, reducing cardiac workload and rapidly restoring blood flow. It can be used both to treat an acute episode and prophylactically, taken a few minutes before anticipated activities known to trigger angina (such as walking in cold weather or climbing stairs). Patients with known angina should always carry their nitroglycerin and know exactly how to use it.

First-Line Anti-Ischemic Medications

Beta-blockers: Drugs such as metoprolol, bisoprolol, and carvedilol reduce the heart’s workload by decreasing heart rate and blood pressure, both at rest and during exertion. They are typically the first choice for long-term anti-ischemic therapy in stable angina, particularly in patients who have had a previous myocardial infarction.

Calcium channel blockers (CCBs): Particularly the non-dihydropyridine types (such as diltiazem and verapamil), these drugs reduce heart rate and cardiac contractility and relax the smooth muscle of the coronary arteries. They are especially effective in variant (vasospastic) angina. Dihydropyridine CCBs (such as amlodipine) primarily work through vasodilation and are often used in combination with beta-blockers.

Long-acting nitrates: Isosorbide mononitrate or dinitrate preparations provide sustained vasodilation throughout the day. It is important to maintain a nitrate-free interval of 8 to 12 hours daily to prevent the development of tolerance.

Second-Line and Combination Anti-Ischemic Agents

When standard therapies are insufficient, contraindicated, or not well tolerated, several additional options are available:

• Ranolazine: Works through a unique mechanism (inhibiting the late inward sodium current in cardiac cells) that reduces myocardial oxygen consumption without significantly affecting heart rate or blood pressure. Particularly useful in patients who cannot tolerate beta-blockers or CCBs.
• Ivabradine: Specifically reduces heart rate by inhibiting the “funny current” in the sinoatrial node, without affecting myocardial contractility. Used in patients in sinus rhythm whose heart rate is inadequately controlled on beta-blockers or who cannot tolerate them.
• Trimetazidine: A metabolic agent that shifts cardiac energy production toward a more oxygen-efficient pathway. Widely used in Europe, particularly in elderly patients and those with heart failure.
• Nicorandil: Combines nitrate-like action with potassium channel opening, providing both coronary vasodilation and cardioprotection.

Cardiovascular Prevention and Plaque Stabilization

This category of medications does not directly relieve angina symptoms but is absolutely essential for reducing the risk of heart attack and death:

Antiplatelet therapy: Low-dose aspirin (75–100 mg daily) reduces platelet aggregation and the risk of blood clot formation within the coronary arteries. In patients who have undergone coronary stenting or who have had an acute coronary syndrome, dual antiplatelet therapy (aspirin plus a P2Y12 inhibitor such as clopidogrel, ticagrelor, or prasugrel) is prescribed for a defined period.

Statins (high-intensity): Statins such as atorvastatin and rosuvastatin at high doses are not merely lipid-lowering drugs; they are anti-atherosclerotic agents. They stabilize existing plaques, reduce inflammation within the arterial wall, partially reverse plaque burden, and dramatically lower the risk of plaque rupture and its consequences. The current target for LDL cholesterol in patients with established coronary artery disease is very stringent: less than 55 mg/dL (1.4 mmol/L) according to European guidelines.

PCSK9 inhibitors: For patients who cannot achieve their LDL target on maximally tolerated statin therapy, injectable PCSK9 inhibitors (evolocumab, alirocumab) provide dramatic additional LDL reduction.

ACE inhibitors or ARBs: Particularly important in patients with accompanying hypertension, diabetes, reduced left ventricular function, or chronic kidney disease, these medications reduce cardiac workload and provide important cardioprotective effects.

Novel cardioprotective agents for patients with diabetes:

• SGLT2 inhibitors (empagliflozin, dapagliflozin, canagliflozin): Originally developed as glucose-lowering drugs, these agents have demonstrated remarkable independent cardiovascular protective effects, including reductions in heart failure hospitalizations, cardiovascular death, and even (in some analyses) myocardial infarction risk.
• GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide): Similarly, these drugs have shown cardiovascular outcome benefits in diabetic patients with established cardiovascular disease.

Revascularization Procedures

When optimal medical therapy fails to adequately control symptoms, or when anatomic imaging or functional testing reveals high-risk coronary anatomy (such as significant stenosis of the left main coronary artery or multiple-vessel severe disease), mechanical revascularization is considered.

Percutaneous Coronary Intervention (PCI) (Angioplasty and Stenting)

Coronary angioplasty with stenting (PCI) is the most commonly performed revascularization procedure. It is performed in the cardiac catheterization laboratory, typically under local anesthesia with sedation:

1. A guide wire is advanced through the catheter to cross the blockage.
2. A small balloon catheter is threaded over the wire and inflated within the narrowed artery segment, compressing the plaque and widening the lumen.
3. A coronary stent, which is a tiny, flexible metal mesh tube, is then deployed at the site of the former obstruction to keep the artery open and prevent re-narrowing (restenosis). Modern drug-eluting stents release anti-proliferative medications to further reduce restenosis rates.

PCI is highly effective at relieving angina symptoms and is particularly suited for single-vessel or limited double-vessel disease.

Coronary Artery Bypass Grafting (CABG)

Bypass surgery (CABG) is a major cardiac surgical procedure in which a cardiothoracic surgeon creates new pathways (bypass grafts) that detour around blocked coronary arteries, restoring blood flow to the ischemic myocardium. The graft vessels are harvested from elsewhere in the patient’s own body, most commonly the internal mammary artery (which provides excellent long-term patency) or the saphenous vein from the leg.

CABG is generally preferred over PCI when:

• Three or more major coronary vessels are significantly diseased (multi-vessel disease)
• The left main coronary artery is significantly stenosed
• Diabetes is present with multi-vessel disease
• The anatomy of the coronary disease is particularly complex and not suitable for stenting

CABG typically provides more durable long-term relief from angina than PCI in these complex cases, though it carries a higher procedural risk in the short term.

The choice between PCI and CABG is a complex clinical decision that should ideally be made by a multidisciplinary “Heart Team” including interventional cardiologists, cardiac surgeons, and the patient themselves.

Lifestyle and Daily Management

No medication or procedure is effective in isolation without meaningful and sustained changes to daily habits. Lifestyle modification is not merely complementary to medical therapy; it is a core, evidence-based component of angina treatment in its own right.

Smoking Cessation

Stopping smoking is the single most powerful intervention available to reduce cardiovascular morbidity and mortality. Within a year of quitting, the excess risk of coronary artery disease begins to fall dramatically. Carbon monoxide levels drop within hours, platelet aggregability improves within days, and endothelial function begins recovering within weeks. Patients should be supported with pharmacological aids (varenicline, nicotine replacement therapy, bupropion) and behavioral counseling.

Cardioprotective Diet

The dietary pattern most strongly supported by evidence for cardiovascular protection is the Mediterranean diet, which is rich in:

• Fresh fruits and vegetables (multiple servings daily)
• Whole grains (oats, barley, whole wheat, brown rice)
• Legumes (beans, lentils, chickpeas)
• Nuts and seeds
• Fish and seafood (particularly oily fish rich in omega-3 fatty acids, such as salmon, mackerel, sardines)
• Olive oil as the primary cooking fat

And low in:

• Saturated and trans fats (fatty red meat, processed meats, full-fat dairy products, fried foods)
• Refined carbohydrates and added sugars
• Excessive sodium (linked to hypertension)
• Ultra-processed foods

Limiting alcohol intake is also strongly recommended, as excessive alcohol consumption raises blood pressure and triglyceride levels and can trigger arrhythmias.

Regular Physical Activity

Paradoxically, many patients with angina fear exercise, as exertion often triggers their symptoms. However, the scientific evidence is unequivocal: regular, appropriately supervised aerobic exercise is one of the most effective treatments for stable angina. It improves:

• Exercise tolerance and symptom threshold
• Endothelial function and coronary microvascular health
• Blood pressure and resting heart rate
• Lipid profile and insulin sensitivity
• Body weight and body composition
• Mental health, quality of life, and overall survival

The ideal setting for initiating exercise in patients with established coronary artery disease is a structured cardiac rehabilitation program, where exercise is supervised, the intensity is individually titrated, and the patient’s response can be monitored safely. These programs are strongly recommended by international guidelines yet remain dramatically underutilized.

For stable angina patients who have completed or do not have access to formal cardiac rehabilitation, the general target is at least 150 minutes of moderate-intensity aerobic activity per week (such as brisk walking, cycling, or swimming), distributed over most days of the week.

Weight Management

Achieving and maintaining a healthy body weight reduces the burden on the heart, lowers blood pressure, improves lipid profiles, and reduces the risk of developing or worsening diabetes. Even modest weight loss (5–10% of body weight) in overweight or obese patients produces significant cardiovascular benefits.

Stress Management and Mental Health

Psychological stress is an independent cardiovascular risk factor. Chronic stress increases circulating catecholamines (stress hormones), raises heart rate and blood pressure, promotes platelet aggregation, and can directly trigger angina episodes. Effective strategies for managing stress include:

• Mindfulness-based stress reduction (MBSR)
• Cognitive-behavioral therapy (CBT), particularly useful for patients with comorbid anxiety or depression
• Regular physical activity (itself an excellent stress reliever)
• Adequate, restorative sleep (7–9 hours per night for most adults)
• Strong social support networks
• Structured relaxation techniques

Screening for and treating depression and anxiety is particularly important in patients with coronary artery disease. These conditions are highly prevalent in this population, significantly worsen prognosis, and reduce adherence to medication and lifestyle recommendations.

Medication Adherence

A critical but often underappreciated aspect of angina management is consistent adherence to prescribed medications. Studies consistently show that a significant proportion of patients do not take their medications as prescribed, leading to inadequate symptom control and substantially increased risks of adverse events. Patients should be educated about:

• The purpose and importance of each medication
• Common side effects and how to manage them
• The danger of abruptly stopping certain medications (particularly beta-blockers and antiplatelets)
• The importance of regular follow-up appointments

---

Prevention

Preventing angina is fundamentally the same as preventing coronary artery disease: by reducing atherosclerotic risk factors and maintaining optimal cardiovascular health. The key preventive measures are:

• Do not smoke, and avoid passive exposure to second-hand smoke.
• Identify and avoid your personal angina triggers: learn which activities, temperatures, or emotional situations provoke your symptoms and plan accordingly.
• Eat a heart-healthy, balanced diet, rich in dietary fiber, fruits, vegetables, whole grains, and lean proteins; minimize saturated fats, added sugars, processed foods, and excessive sodium.
• Stay physically active in accordance with your current health status and any advice from your doctor or cardiac rehabilitation team.
• Achieve and maintain a healthy weight. If you are overweight or obese, losing even a modest amount of weight has meaningful cardiovascular benefits.
• Learn effective stress management techniques, including relaxation exercises, adequate sleep, and seeking psychological support when needed.
• Take all prescribed medications consistently, both those that relieve symptoms and those that protect against future cardiac events.
• Monitor your cardiovascular risk factors regularly: cholesterol, blood glucose, blood pressure, and weight. Know your numbers and work with your doctor to achieve your individual targets.
• Sleep well: Chronic poor sleep is associated with higher blood pressure, increased inflammation, and a greater risk of cardiovascular events. Screening for and treating conditions like obstructive sleep apnea is particularly important in patients with coronary artery disease.
• Report any new, unusual, or worsening symptoms to your doctor promptly. A change in the pattern of your angina, such as more frequent episodes, occurring at lower levels of exertion, lasting longer, or responding less well to medication, should never be ignored or attributed to “just stress”.

---

Frequently Asked Questions

What is angina pectoris?

Angina pectoris is chest pain or discomfort caused by reduced blood flow to the heart muscle. It is a warning symptom of underlying coronary artery disease, not a disease in itself. While it is not usually immediately life-threatening, it is a serious signal indicating a significantly elevated risk of future heart attack or stroke, and it always requires medical evaluation and management.

When should I be concerned about angina?

If you have never been diagnosed with angina and you experience new chest pain or discomfort, you should seek emergency medical attention immediately, especially if the pain lasts more than a few minutes, does not improve with rest, radiates to your arm, jaw, or back, or is accompanied by shortness of breath, sweating, or nausea. Do not drive yourself; call emergency services.

If you already have a diagnosis of angina and you experience a typical episode, you should: stop the activity you are engaged in, sit or lie down, and take your prescribed nitroglycerin as directed. If the pain does not resolve within a few minutes, or if the episode is more severe or prolonged than usual, treat it as a potential heart attack: call emergency services immediately without further delay.

Can angina be cured?

Angina can in many cases be very effectively controlled, to the point where patients can live full, active lives, through a combination of appropriate medications, lifestyle changes, and, when necessary, revascularization procedures. Whether it can be “cured” in the strict sense depends on its cause and severity, as well as how aggressively risk factors are modified. The underlying coronary artery disease can be stabilized and even partially reversed with aggressive medical therapy, but this requires long-term commitment.

Is angina the same as a heart attack?

No, though they share the same underlying mechanism (insufficient blood flow to the heart), they are importantly different. In angina, blood flow is reduced but not completely interrupted, and heart muscle cells are temporarily oxygen-deprived but not permanently damaged. In a heart attack, blood flow is completely blocked, and heart muscle cells begin to die permanently. The key distinguishing features are: heart attack pain is more severe, lasts longer (more than 20–30 minutes), and is not relieved by rest or nitroglycerin.

---

Sources and Bibliography

• NIH – National Heart, Lung, and Blood Institute: Angina
• Knuuti J, et al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. European Heart Journal, 2020.
• Vrints C, et al. 2024 ESC Guidelines for the management of chronic coronary syndromes. European Heart Journal, 2024.
• Lawton JS, et al. 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization. Journal of the American College of Cardiology, 2022.
• Fihn SD, et al. 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease. Circulation, 2012.
• Bairey Merz CN, et al. Ischemia and No Obstructive Coronary Artery Disease (INOCA). Circulation, 2017.
• ANMCO/SIC: Italian Guidelines on the management of chronic ischemic heart disease.
• Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. New England Journal of Medicine, 2005.
• Piepoli MF, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal, 2016.